Home / Letter From The Editor / Jan. 9, 2021

Jan. 9, 2021

Jan 9, 2021

I was able to get my first dose of the Moderna vaccine this morning. Our local hospital was making it available to healthcare providers and patients over 65, and I qualified on both accounts. The process was smooth and the injection was painless. They have a waiting area where you have to stay for 15-20 minutes to make sure there isn’t a severe allergic reaction.

While I was sitting there, a PharmD intern and a medical intern were walking around asking questions and offering information. They were both from the LECOM Colleges of Pharmacy and Medicine. As we were chatting the subject turned to diabetes, of course, and they both were asking about the use of GLP-1 agonists in diabetes patients. We started discussing the merits of daily or weekly dosing and which offered better control.


I was able to refer them to an article prepared by Destiny Funchess, PharmD Candidate, South College School of Pharmacy, that compared the differences, similarities and benefits of both regimens. Click here to read our Laterpay feature and find out which one to choose for your patients.



We can make a difference!


Dave Joffe